Additional Gene Therapy with rAAV-wt-p53 Enhanced the Efficacy of Cisplatin in Human Bladder Cancer Cells

Publisher： Karger

E-ISSN： 1423-0399|77|4|355-361

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.77, Iss.4, 2006-11, pp. : 355-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p53 Gene Mutations in Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 73, Iss. 3, 2004-11 ,pp. : 212-218

Karger

Access to resources Recommend Favorite

Chemoresistance of Cancer Cells: Oncogenic Mutation of the p53 Tumor Suppressor Gene

By  

Current Signal Transduction Therapy, Vol. 11, Iss. 1, 2016-04 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

Anti‐Proliferative Effects of Polyphenols from Pomegranate Rind (Punica granatum L.) on EJ Bladder Cancer Cells Via Regulation of p53/miR‐34a Axis

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 3, 2015-03 ,pp. : 415-422

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen-modulated p21 and p53 gene expression in human non-transformed epithelial prostatic cells in primary cultures

By      

International Journal of Molecular Medicine, Vol. 30, Iss. 4, 2012-01 ,pp. : 967-973

Spandidos Publications

Access to resources Recommend Favorite

Combined Effects of p53 Gene Therapy and Leptomycin B in Human Esophageal Squamous Cell Carcinoma

By  

Oncology, Vol. 75, Iss. 1-2, 2008-09 ,pp. : 113-119

Karger

Access to resources Recommend Favorite